Literature DB >> 9458275

Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia.

W E Connor1, D S Lin, G Thomas, F Ey, T DeLoughery, N Zhu.   

Abstract

As the lipid composition of cell membranes has significant effects upon cellular function, we hypothesized that the membranes of sickle cells might have a distorted lipid composition. Accordingly, we analyzed the molecular species of the choline and ethanolamine glycerophospholipids, the fatty acid composition of the total phospholipids and of the five major individual phospholipids of erythrocytes from 8 patients with sickle cell anemia and from 14 normal subjects. Of the 31 molecular species identified for each subclass of the glycerophospholipids, 12 were found to be distinctly abnormal. Sickle cells contained more molecular species with saturated and monounsaturated fatty acid at the sn-2 position and fewer molecular species with polyunsaturated fatty acids at the sn-2 position. The values ranged from 20 to 60% above or below normal values. In diacyl choline glycerophospholipids (outer membrane leaflet), sickle erythrocytes contained lower amounts of the 16:0-18:2 species and higher 16:0-18:1 and 16:0-16:0 species. In diacyl ethanolamine glycerophospholipid (inner membrane leaflet), sickle erythrocytes had lower amounts of 18:0-22:6; 16:0-22:4; 18:0-18:2; 18:1-18:2; and 18:1-20:3. In phosphatidylcholine and phosphatidylethanolamine, sickle erythrocytes contained less linoleic acid, less docosahexaenoic acid (30-40%) and more oleic and palmitic acids (20-30%) compared to normal erythrocytes. These same differences were seen also in the total phospholipids. Our data demonstrated distinct abnormalities of the phospholipid molecular species composition in the membrane lipids of sickle erythrocytes. These defects might have a role in one or more known metabolic abnormalities of sickle cell disease including cation imbalance, dehydration, disturbed membrane phospholipid asymmetry, and hypercoagulability. Furthermore, detailed information of the phospholipid molecular species composition of normal erythrocytes was provided.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9458275

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea.

Authors:  Cristiane O Renó; Amanda Rodrigues Barbosa; Sara Santos de Carvalho; Melina B Pinheiro; Danyelle Romana Rios; Vanessa F Cortes; Leandro A Barbosa; Hérica L Santos
Journal:  Ann Hematol       Date:  2020-03-12       Impact factor: 3.673

2.  Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial).

Authors:  Ahmed A Daak; Carlton D Dampier; Beng Fuh; Julie Kanter; Ofelia A Alvarez; L Vandy Black; Melissa A McNaull; Michael U Callaghan; Alex George; Lynne Neumayr; Lee M Hilliard; Fredrick Sancilio; Adrian L Rabinowicz; Matthew M Heeney
Journal:  Blood Adv       Date:  2018-08-14

3.  Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia.

Authors:  B N Yamaja Setty; Suhita Gayen Betal; Robin E Miller; Dawn S Brown; Maureen Meier; Michele Cahill; Norma B Lerner; Nataly Apollonsky; Marie J Stuart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2019-05-10       Impact factor: 4.006

4.  sn-position determination of phospholipid-linked fatty acids derived from erythrocytes by liquid chromatography electrospray ionization ion-trap mass spectrometry.

Authors:  Christopher Beermann; Michael Möbius; Nadine Winterling; Joachim J Schmitt; Günther Boehm
Journal:  Lipids       Date:  2005-02       Impact factor: 1.880

5.  LC-MS/MS analysis of plasma polyunsaturated fatty acids in patients with homozygous sickle cell disease.

Authors:  Mutay Aslan; Gamze Celmeli; Filiz Özcan; Alphan Kupesiz
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

6.  Characterization and statistical modeling of glycosylation changes in sickle cell disease.

Authors:  Heather E Ashwood; Christopher Ashwood; Anna P Schmidt; Rebekah L Gundry; Karin M Hoffmeister; Waseem Q Anani
Journal:  Blood Adv       Date:  2021-03-09

7.  Characterization of acyl chain position in unsaturated phosphatidylcholines using differential mobility-mass spectrometry.

Authors:  Alan T Maccarone; Jackson Duldig; Todd W Mitchell; Stephen J Blanksby; Eva Duchoslav; J Larry Campbell
Journal:  J Lipid Res       Date:  2014-06-17       Impact factor: 5.922

8.  Hydroxyurea therapy mobilises arachidonic Acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell disease.

Authors:  A A Daak; K Ghebremeskel; M I Elbashir; A Bakhita; Z Hassan; M A Crawford
Journal:  J Lipids       Date:  2011-09-15

9.  Hypoxia-mediated impaired erythrocyte Lands' Cycle is pathogenic for sickle cell disease.

Authors:  Hongyu Wu; Mikhail Bogdanov; Yujin Zhang; Kaiqi Sun; Shushan Zhao; Anren Song; Renna Luo; Nicholas F Parchim; Hong Liu; Aji Huang; Morayo G Adebiyi; Jianping Jin; Danny C Alexander; Michael V Milburn; Modupe Idowu; Harinder S Juneja; Rodney E Kellems; William Dowhan; Yang Xia
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

10.  Phase angle correlates with n-3 fatty acids and cholesterol in red cells of Nigerian children with sickle cell disease.

Authors:  Dorothy J VanderJagt; Miguel R Trujillo; Fidelia Bode-Thomas; Yung-Sheng Huang; Lu-Te Chuang; Robert H Glew
Journal:  Lipids Health Dis       Date:  2003-05-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.